- Analyst Confidence: Piper Sandler raised its price target for UnitedHealth Group (NYSE:UNH) to $475, indicating a potential 13.3% upside.
- Strong Buy Rating: The company holds an average brokerage recommendation of 1.46 (Strong Buy/Buy) from 27 firms, with 20 recommending a “Strong Buy.”
- Consistent Performance: UnitedHealth Group has consistently beaten earnings estimates, with its last reported $7.23 EPS significantly exceeding expectations.
UnitedHealth Group (NYSE:UNH) is the largest health insurer in the United States, also operating its large Optum health services business. On July 15, 2026, an analyst from Piper Sandler raised their price target for UnitedHealth Group to $475 from $420. This new target suggests a potential upside of approximately 13.3% from its price of $419.23 at the time.
This positive view is shared by many on Wall Street. As highlighted by Zacks, UnitedHealth Group has an average brokerage recommendation of 1.46 on a one-to-five scale, which is similar to a “Strong Buy” or “Buy” rating. This consensus comes from 27 brokerage firms, with 20 of them giving the stock a “Strong Buy” recommendation.
The company’s strong performance supports this analyst confidence. UnitedHealth has a history of beating earnings estimates, surpassing them by an average of 6.44% over the last two quarters. In the last reported quarter, its earnings of $7.23 per share were nearly 12% higher than the Zacks Consensus Estimate of $6.46 per share.
As the company prepares for its next earnings report, investors are watching closely. As noted by Benzinga, analysts expect earnings per share of $4.85 with revenue of $110.77 billion. Key areas of focus will be the growth in Medicare Advantage memberships and the performance of the Optum services and pharmacy benefit businesses.
